TerrAscend — Investor Relations & Filings
Filings indexed
608
across all filing types
Latest filing
2026-05-15
Transaction in Own Shar…
Country
CA
Canada
Listing
TSX
TSND
TerrAscend is a vertically integrated cannabis operator specializing in cultivation, processing, manufacturing, and retail distribution across key North American markets. The company maintains scaled operations in multiple states, including California, Maryland, New Jersey, Ohio, and Pennsylvania, serving both medical and adult-use consumers. Retail operations are conducted through award-winning dispensary brands such as The Apothecarium and Gage. TerrAscend's product portfolio includes high-quality cannabis flower, concentrates, vaporizables, and whole-plant hemp extracts. The core business strategy emphasizes quality, innovation, and consistency in product development, aiming to meet the evolving needs of its customer base.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release (section 4.8 of NI 62-104) – English.pdf | 2026-05-15 | English | |
| News release (section 4.8 of NI 62-104) – English.pdf | 2026-05-15 | English | |
| Other.pdf | 2026-05-07 | English | |
| 52-109F2 - Certification of interim filings - CEO (E).pdf | 2026-05-07 | English | |
| Interim MD&A - English.pdf | 2026-05-07 | English | |
| Other.pdf | 2026-05-07 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47801845 | News release (section 4.8 of NI 62-104) – English.pdf | 2026-05-15 | English | ||
| 47801848 | News release (section 4.8 of NI 62-104) – English.pdf | 2026-05-15 | English | ||
| 47357678 | Other.pdf | 2026-05-07 | English | ||
| 47357682 | 52-109F2 - Certification of interim filings - CEO (E).pdf | 2026-05-07 | English | ||
| 47357686 | Interim MD&A - English.pdf | 2026-05-07 | English | ||
| 47357690 | Other.pdf | 2026-05-07 | English | ||
| 47357694 | News release - English.pdf | 2026-05-07 | English | ||
| 37453853 | News release - English.pdf | 2026-04-27 | English | ||
| 37453707 | News release - English.pdf | 2026-04-27 | English | ||
| 34651347 | Form of proxy - English.pdf | 2026-04-16 | English | ||
| 34651339 | Management information circular - English.pdf | 2026-04-16 | English | ||
| 34651338 | Notice of meeting - English.pdf | 2026-04-16 | English | ||
| 34651337 | Other.pdf | 2026-04-16 | English | ||
| 34650679 | Management information circular - English.pdf | 2026-04-16 | English | ||
| 34650678 | Notice of meeting - English.pdf | 2026-04-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CAPRICOR THERAPEUTICS, INC.
A clinical-stage biotech developing cell and exosome-based …
|
CAPR | US | Manufacturing |
|
Cardiogeni Plc
A clinical-stage biotech developing regenerative medicines …
|
— | GB | Manufacturing |
|
Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory and ant…
|
CRDL | CA | Manufacturing |
|
CAREGEN CO.,LTD.
Develops biomimetic peptides and growth factors for aesthet…
|
214370 | KR | Manufacturing |
|
Caribou Biosciences, Inc.
Clinical-stage biopharma developing genome-edited allogenei…
|
CRBU | US | Manufacturing |
|
Carisma Therapeutics Inc.
A clinical-stage biotech developing engineered macrophage-b…
|
CARM | US | Manufacturing |
|
Carna Biosciences, Inc.
Clinical-stage biopharma developing small molecule kinase i…
|
4572 | JP | Manufacturing |
|
CARsgen Therapeutics Holdings Limited
Clinical-stage biopharma focused on developing innovative C…
|
2171 | HK | Manufacturing |
|
Cartesian Therapeutics, Inc.
A clinical-stage company developing mRNA-engineered cell th…
|
RNAC | US | Manufacturing |
|
CASI Pharmaceuticals, Inc.
Biopharmaceutical firm developing therapeutics for organ tr…
|
CASI | US | Manufacturing |
TerrAscend via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47415/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47415 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47415 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47415 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47415}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TerrAscend (id: 47415)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.